<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35155636</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Cardio-Oncology in the COVID Era (Co &amp; Co): The Never Ending Story.</ArticleTitle><Pagination><StartPage>821193</StartPage><MedlinePgn>821193</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">821193</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2022.821193</ELocationID><Abstract><AbstractText>The pathophysiology of some non-communicable diseases (NCDs) such as hypertension, cardiovascular disease (CVD), diabetes, and cancer includes an alteration of the endothelial function. COVID-19 is a pulmonary and vascular disease with a negative impact on patients whose damaged endothelium is particularly vulnerable. The peculiar SARS-CoV-2-induced "endothelitis" triggers an intriguing immune-thrombosis that affects both the venous and arterial vascular beds. An increased liability for infection and an increased likelihood of a worse outcome have been observed during the pandemic in patients with active cancer and in cancer survivors. "Overlapping commonalities" between COVID-19 and Cardio-Oncology have been described that include shared phenotypes of cardiovascular toxicities such as left ventricular dysfunction, ischemic syndromes, conduction disturbances, myocarditis, pericarditis and right ventricular failure; shared pathophysiologic mechanisms such as inflammation, release of cytokines, the renin-angiotensin-aldosterone-pathway, coagulation abnormalities, microthrombosis and endothelial dysfunction. For these features and for the catalyst role of NCDs (mainly CVD and cancer), we should refer to COVID-19 as a "syndemic." Another challenging issue is the persistence of the symptoms, the so-called "long COVID" whose pathogenesis is still uncertain: it may be due to persistent multi-organ viral attacks or to an abnormal immune response. An intensive vaccination campaign is the most successful pharmacological weapon against SARS-CoV-2, but the increasing number of variants has reduced the efficacy of the vaccines in controlling SARS-CoV-2 infections. After a year of vaccinations we have also learned more about efficacy and side-effects of COVID-19 vaccines. An important byproduct of the COVID-19 pandemic has been the rapid expansion of telemedicine platforms across different care settings; this new modality of monitoring cancer patients may be useful even in a post pandemic era. In this paper we analyze the problems that the cardio-oncologists are facing in a pandemic scenario modified by the extensive vaccination campaign and add actionable recommendations derived from the ongoing studies and from the syndemic nature of the infection.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Bisceglia, Canale, Gallucci, Turazza, Lestuzzi, Parrini, Russo, Maurea, Quagliariello, Oliva, Di Fusco, Luc&#xe0;, Tarantini, Trambaiolo, Moreo, Geraci, Gabrielli, Gulizia, Oliva and Colivicchi.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bisceglia</LastName><ForeName>Irma</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Integrated Cardiology Services, Cardio-Thoracic-Vascular Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canale</LastName><ForeName>Maria Laura</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Cardiology Department, Nuovo Ospedale Versilia Lido di Camaiore Lucca, Camaiore, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallucci</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardio-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turazza</LastName><ForeName>Fabio Maria</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Cardiology Department, National Cancer Institute Foundation, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lestuzzi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Azienda Sanitaria Friuli Occidentale (ASFO) Cardiac and Cardio-Oncologic Rehabilitation Service at Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrini</LastName><ForeName>Iris</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Cardiology Department, Ospedale Mauriziano Umberto I, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russo</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiovascular and Sports Medicine Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maurea</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiology Department, G. Pascale National Cancer Institute Foundation (IRCCS), Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quagliariello</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cardiology Department, G. Pascale National Cancer Institute Foundation (IRCCS), Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliva</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardio-Oncology Department, Istituto Tumori Giovanni Paolo II, Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Fusco</LastName><ForeName>Stefania Angela</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Clinical and Rehabilitation Cardiology Department, Ospedale San Filippo Neri, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luc&#xe0;</LastName><ForeName>Fabiana</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiology Department, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarantini</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiology Department, Santa Maria Nuova Hospital, Reggio Emilia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trambaiolo</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Divisione di Cardiologia, Arcispedale S. Maria Nuova, Azienda Unit&#xe0; Sanitaria Locale-IRCCS di Reggio-Emilia, Reggio Emilia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreo</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>A. De Gasperis Cardio Center, Aziende Socio Sanitarie Territoriali (ASST) Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geraci</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiology Unit, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabrielli</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic-Vascular Department, San Camillo-Forlanini Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulizia</LastName><ForeName>Michele Massimo</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Cardiology Department, Garibaldi Hospital, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliva</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Dipartimento Cardiotoracovascolare, Cardiology 1-Cath Lab, Coronary Care Unit (CCU), ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colivicchi</LastName><ForeName>Furio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Clinical and Rehabilitation Cardiology Department, Ospedale San Filippo Neri, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Front Cardiovasc Med. 2022 May 13;9:903766. doi: 10.3389/fcvm.2022.903766</RefSource><PMID Version="1">35647054</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Front Cardiovasc Med. 2023 Mar 09;10:1169176. doi: 10.3389/fcvm.2023.1169176</RefSource><PMID Version="1">36970365</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">cardiotoxicity</Keyword><Keyword MajorTopicYN="N">cardiovascular disease</Keyword><Keyword MajorTopicYN="N">syndemic</Keyword><Keyword MajorTopicYN="N">telehealth</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>14</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35155636</ArticleId><ArticleId IdType="pmc">PMC8831543</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2022.821193</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Horton R. Offline: COVID-19 is not a pandemic. Lancet. (2020) 396:874. 10.1016/S0140-6736(20)32000-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32000-6</ArticleId><ArticleId IdType="pmc">PMC7515561</ArticleId><ArticleId IdType="pubmed">32979964</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W, Huang N, B&#xe9;cavin C, Berg M, Queen R, Litvinukova M, et al. . Lung biological network. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med. (2020) 26:681&#x2013;7. 10.1038/s41591-020-0868-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res. (2020) 30:367&#x2013;9. 10.1038/s41422-020-0327-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-0327-4</ArticleId><ArticleId IdType="pmc">PMC7186532</ArticleId><ArticleId IdType="pubmed">32346073</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles VG, L&#xfc;tgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. . Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. (2020) 383:590&#x2013;92. 10.1056/NEJMc2011400</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. (2020) 526:135&#x2013;40. 10.1016/j.bbrc.2020.03.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.03.044</ArticleId><ArticleId IdType="pmc">PMC7156119</ArticleId><ArticleId IdType="pubmed">32199615</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, et al. . HCA lung biological network. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. (2020) 181:1016&#x2013;35.e19. 10.1016/j.cell.2020.04.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.035</ArticleId><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. . Extrapulmonary manifestations of COVID-19. Nat Med. (2020) 26:1017&#x2013;32. 10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. (2004) 203:631&#x2013;7. 10.1002/path.1570</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi HK, Libby P, Ridker PM. COVID-19 - A vascular disease. Trends Cardiovasc Med. (2021) 31:1&#x2013;5. 10.1016/j.tcm.2020.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>https://ourworldindata.com (accessed October 30, 2021).</Citation></Reference><Reference><Citation>Yusuf A, Sarfati D, Booth CM, Pramesh CS, Lombe D, Aggarwal A, et al. . Covid-19 and cancer global taskforce. Cancer and COVID-19 vaccines: a complex global picture. Lancet Oncol. (2021) 22:749&#x2013;51. 10.1016/S1470-2045(21)00244-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(21)00244-8</ArticleId><ArticleId IdType="pmc">PMC8078890</ArticleId><ArticleId IdType="pubmed">33930324</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. . Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. (2021) 92:55&#x2013;70. 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisceglia I, Gabrielli D, Canale ML, Gallucci G, Parrini I, Turazza FM, et al. . ANMCO position paper: cardio-oncology in the COVID-19 era. G Ital Cardiol. (2021) 22:800&#x2013;25. 10.1714/3666.36511</Citation><ArticleIdList><ArticleId IdType="doi">10.1714/3666.36511</ArticleId><ArticleId IdType="pubmed">34570114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisceglia I, Gabrielli D, Canale ML, Gallucci G, Parrini I, Turazza FM, et al. . ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO). Eur Heart J Suppl. (2021) 23(Suppl. C):C128&#x2013;53. 10.1093/eurheartj/suab067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/suab067</ArticleId><ArticleId IdType="pmc">PMC8388610</ArticleId><ArticleId IdType="pubmed">34456641</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. (2020) 6:1108&#x2013;10. 10.1001/jamaoncol.2020.0980</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2020.0980</ArticleId><ArticleId IdType="pmc">PMC7097836</ArticleId><ArticleId IdType="pubmed">32211820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KA, Ma W, Sikavi DR, Drew DA, Nguyen LH, Bowyer RCE, et al. . COPE consortium. Cancer and Risk of COVID-19 through a general community survey. Oncologist. (2021) 26:e182&#x2013;5. 10.1634/theoncologist.2020-0572</Citation><ArticleIdList><ArticleId IdType="doi">10.1634/theoncologist.2020-0572</ArticleId><ArticleId IdType="pmc">PMC7460944</ArticleId><ArticleId IdType="pubmed">32845538</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. . Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. (2020) 21:335&#x2013;37. 10.1016/S1470-2045(20)30096-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(20)30096-6</ArticleId><ArticleId IdType="pmc">PMC7159000</ArticleId><ArticleId IdType="pubmed">32066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Waissengrin B, Agbarya A, Safadi E, Padova H, Wolf I. Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors. Lancet Oncol. (2021) 22:581&#x2013;3. 10.1016/S1470-2045(21)00155-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(21)00155-8</ArticleId><ArticleId IdType="pmc">PMC8016402</ArticleId><ArticleId IdType="pubmed">33812495</ArticleId></ArticleIdList></Reference><Reference><Citation>Tepasse PR, Hafezi W, Lutz M, K&#xfc;hn J, Wilms C, Wiewrodt R, et al. . Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature. Br J Haematol. (2020) 90:185&#x2013;8. 10.1111/bjh.16896</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16896</ArticleId><ArticleId IdType="pmc">PMC7300950</ArticleId><ArticleId IdType="pubmed">32557623</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcacci G, Fiorentino G, Volzone F, Falcone U, Parrella R, Donnarumma D, et al. . Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab. Infect Agent Cancer. (2021) 16:38. 10.1186/s13027-021-00376-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13027-021-00376-1</ArticleId><ArticleId IdType="pmc">PMC8170447</ArticleId><ArticleId IdType="pubmed">34078415</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda H, Tsukune Y, Watanabe N, Sugimoto K, Uchimura A, Tateyama M, et al. . Persistent COVID-19 pneumonia and failure to develop anti-SARS-CoV-2 antibodies during rituximab maintenance therapy for follicular lymphoma. Clin Lymphoma Myeloma Leuk. (2020) 20:774&#x2013;6. 10.1016/j.clml.2020.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clml.2020.08.017</ArticleId><ArticleId IdType="pmc">PMC7442568</ArticleId><ArticleId IdType="pubmed">32933879</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijenthira A, Gong IY, Fox TA, Booth S, Cook G, Fattizzo B, et al. . Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3,377 patients. Blood. (2020) 136:2881&#x2013;92. 10.1182/blood.2020008824</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020008824</ArticleId><ArticleId IdType="pmc">PMC7746126</ArticleId><ArticleId IdType="pubmed">33113551</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen KM, Bates BA, Rashidi ES, Olex AL, Mannon RB, Patel RC, et al. . Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the national COVID cohort collaborative. Lancet Rheumatol. (2022) 4:e33&#x2013;41. 10.1016/S2665-9913(21)00325-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00325-8</ArticleId><ArticleId IdType="pmc">PMC8592562</ArticleId><ArticleId IdType="pubmed">34806036</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. (2021) 395:1054&#x2013;62. 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, et al. . Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. (2021) 76:428&#x2013;55. 10.1111/all.14657</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. . Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China [published online March 25, 2020]. JAMA Cardiol. (2020) 5:802&#x2013;10. 10.1001/jamacardio.2020.0950</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Guan B, Su T, Liu W, Chen M, Bin Waleed K, et al. . Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart. (2020) 106:1142&#x2013;7. 10.1136/heartjnl-2020-317062</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2020-317062</ArticleId><ArticleId IdType="pmc">PMC7295861</ArticleId><ArticleId IdType="pubmed">32461330</ArticleId></ArticleIdList></Reference><Reference><Citation>Lala A, Johnson KW, Januzzi JL, Russak AJ, Paranjpe I, Richter F, et al. . Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol. (2020) 76:533&#x2013;46. 10.1016/j.jacc.2020.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.007</ArticleId><ArticleId IdType="pmc">PMC7279721</ArticleId><ArticleId IdType="pubmed">32517963</ArticleId></ArticleIdList></Reference><Reference><Citation>Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: Cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. (2021) 50:107300. 10.1016/j.carpath.2020.107300</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carpath.2020.107300</ArticleId><ArticleId IdType="pmc">PMC7583586</ArticleId><ArticleId IdType="pubmed">33132119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace M, Oliver S. COVID-19 mRNA Vaccines in Adolescents and Young Adults: Benefit-Risk Discussion. Available online at; https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-06/05-COVID-Wallace-508.pdf (accessed July 7, 2021).</Citation></Reference><Reference><Citation>Diaz GA, Parsons GT, Gering SK, Meier AR, Hutchinson IV, Robicsek A, et al. . Myocarditis and pericarditis after vaccination for COVID-19. JAMA. (2021) 326:34347001. 10.1001/jama.2021.13443</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.13443</ArticleId><ArticleId IdType="pmc">PMC8340007</ArticleId><ArticleId IdType="pubmed">34347001</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SA, Zaharova S, Mason P, Thompson J, Thapa B, Ishizawar D, et al. . Perspective: commonalities between COVID-19 and cardio-oncology. Front Cardiovasc Med. (2020) 7:568720. 10.3389/fcvm.2020.568720</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.568720</ArticleId><ArticleId IdType="pmc">PMC7746643</ArticleId><ArticleId IdType="pubmed">33344513</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozahic C, Maddock H, Sandhu H. Anti-cancer therapy leads to increased cardiovascular susceptibility to COVID-19. Front Cardiovasc Med. (2021) 8:634291. 10.3389/fcvm.2021.634291</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.634291</ArticleId><ArticleId IdType="pmc">PMC8102732</ArticleId><ArticleId IdType="pubmed">33969006</ArticleId></ArticleIdList></Reference><Reference><Citation>Late Sequelae of COVID-19 . Available online at: https://stacks.cdc.gov/view/cdc/97200/cdc_97200_DS1.pdf (accessed February 26, 2021).</Citation></Reference><Reference><Citation>Fogarty H, Townsend L, Morrin H, Ahmad A, Comerford C, Karampini E, et al. . Irish COVID-19 vasculopathy study (CVS) investigators persistent endotheliopathy in the pathogenesis of long COVID syndrome. J Thromb Haemost. (2021) 19:2546&#x2013;53. 10.1111/jth.15490</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini G, Aneja R. Cancer as a prospective sequela of long COVID-19. Bioessays. (2021) 43:e2000331. 10.1002/bies.202000331</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.202000331</ArticleId><ArticleId IdType="pmc">PMC8206711</ArticleId><ArticleId IdType="pubmed">33914346</ArticleId></ArticleIdList></Reference><Reference><Citation>Teijaro JR, Farber DL. COVID-19 vaccines: modes of immune activation and future challenges. Nat Rev Immunol. (2021) 21:195&#x2013;7. 10.1038/s41577-021-00526-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00526-x</ArticleId><ArticleId IdType="pmc">PMC7934118</ArticleId><ArticleId IdType="pubmed">33674759</ArticleId></ArticleIdList></Reference><Reference><Citation>Magliulo D, Wade SD, Kyttaris VC. Immunogenicity of SARS-CoV-2 vaccination in rituximab-treated patients: effect of timing and immunologic parameters. Cliical Immunol. (2022) 234:108897. 10.1016/j.clim.2021.108897</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2021.108897</ArticleId><ArticleId IdType="pmc">PMC8627008</ArticleId><ArticleId IdType="pubmed">34848357</ArticleId></ArticleIdList></Reference><Reference><Citation>Madelon N, Lauper K, Breville G, Sabater Royo I, Goldstein R, Andrey DO, et al. . Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study. Clin Infect Dis. (2021) ciab954. 10.1093/cid/ciab954</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab954</ArticleId><ArticleId IdType="pmc">PMC8767893</ArticleId><ArticleId IdType="pubmed">34791081</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. (2020) 14:395&#x2013;403. 10.1016/j.dsx.2020.04.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.04.018</ArticleId><ArticleId IdType="pmc">PMC7162793</ArticleId><ArticleId IdType="pubmed">32334395</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilazi M, Duffy EY, Thakkar A, Michos ED. COVID and cardiovascular disease: what we know in 2021. Curr Atheroscler Rep. (2021) 23:37. 10.1007/s11883-021-00935-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-021-00935-2</ArticleId><ArticleId IdType="pmc">PMC8117457</ArticleId><ArticleId IdType="pubmed">33983522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawakami R, Sakamoto A, Kawai K, Gianatti A, Pellegrini D, Nasr A, et al. . Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC review topic of the week. J Am Coll Cardiol. (2021) 77:314&#x2013;25. 10.1016/j.jacc.2020.11.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.11.031</ArticleId><ArticleId IdType="pmc">PMC7816957</ArticleId><ArticleId IdType="pubmed">33478655</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi G, Pellegrini C, Maurelli M, Belliato M, Sciutti F, Bottazzi A, et al. . Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. (2020) 22:911&#x2013;5. 10.1002/ejhf.1828</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1828</ArticleId><ArticleId IdType="pmc">PMC7262276</ArticleId><ArticleId IdType="pubmed">32275347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala S, Peretto G, Gramegna M, Palmisano A, Villatore A, Vignale D, et al. . Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. (2020) 41:1861&#x2013;2. 10.1093/eurheartj/ehaa286</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa286</ArticleId><ArticleId IdType="pmc">PMC7184339</ArticleId><ArticleId IdType="pubmed">32267502</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. (2020) 46:1294&#x2013;7. 10.1007/s00134-020-06028-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06028-z</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Mele D, Flamigni F, Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: current problems. Intern Emerg Med. (2021) 16:1123&#x2013;9. 10.1007/s11739-021-02635-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-021-02635-w</ArticleId><ArticleId IdType="pmc">PMC7823176</ArticleId><ArticleId IdType="pubmed">33484452</ArticleId></ArticleIdList></Reference><Reference><Citation>Metkus TS, Sokoll LJ, Barth AS, Czarny MJ, Hays AG, Lowenstein CJ&#x201e; et al. Myocardial injury in severe COVID-19 compared with non-COVID-19 acute respiratory distress syndrome. Circulation. (2021) 143:553&#x2013;65. 10.1161/CIRCULATIONAHA.120.050543</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.050543</ArticleId><ArticleId IdType="pmc">PMC7864609</ArticleId><ArticleId IdType="pubmed">33186055</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G, Croft LB, Stefanini GG, Bragato R, Silbiger JJ, Vicenzi M, et al. . Characterization of myocardial injury in patients with COVID-19. J Am Coll Cardiol. (2020) 76:2043&#x2013;55. 10.1016/j.jacc.2020.08.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.069</ArticleId><ArticleId IdType="pmc">PMC7588179</ArticleId><ArticleId IdType="pubmed">33121710</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario CM, Jessup J, Chappell MC, Averill DB, Brosnihan KB, Ann Tallant E, et al. . Effect of angiotensin-converting enzyme inhibition and angiotensin ii receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. (2005) 111:2605&#x2013;10. 10.1161/CIRCULATIONAHA.104.510461</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.510461</ArticleId><ArticleId IdType="pubmed">15897343</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Zhu L, Cai J, Lei F, Qin JJ, Xie J, et al. . Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. (2020) 126:1671&#x2013;81. 10.1161/CIRCRESAHA.120.317134</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317134</ArticleId><ArticleId IdType="pmc">PMC7265882</ArticleId><ArticleId IdType="pubmed">32302265</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin&#x2013;angiotensin&#x2013;aldosterone system inhibitors in patients with Covid-19. N Engl J Med. (2020) 382:1653&#x2013;9. 10.1056/NEJMsr2005760</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsr2005760</ArticleId><ArticleId IdType="pmc">PMC7121452</ArticleId><ArticleId IdType="pubmed">32227760</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Chen B, Li Y, Zhang L, Wang Y, Yang S, et al. . The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: a systematic review and meta-analysis. J Med Virol. (2021) 93:1370&#x2013;7. 10.1002/jmv.26625</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26625</ArticleId><ArticleId IdType="pubmed">33095513</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B, Kovacs R, Harrington B. Joint HFSA/ACC/AHA statement addresses concerns Re: using RAAS antagonists in COVID-19. J Cardiac Fail. (2020) 26:370. 10.1016/j.cardfail.2020.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7234783</ArticleId><ArticleId IdType="pubmed">32439095</ArticleId></ArticleIdList></Reference><Reference><Citation>De Simone G. Position statement of the ESC council on hypertension on ACE-inhibitors and angiotensin receptor blockers. Eur Soc Cardiol. (2020) 13.</Citation></Reference><Reference><Citation>Chinese Society of Cardiology . Scientific statement on using renin&#x2013;angiotensin system blockers in patients with cardiovascular disease and COVID-19. Chin J Cardiol. (2020) 48:E014. 10.3760/cma.j.issn.0253-3758.2020.0014</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0253-3758.2020.0014</ArticleId><ArticleId IdType="pubmed">32283876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. (2021) 144:471&#x2013;84. 10.1161/CIRCULATIONAHA.121.056135</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.056135</ArticleId><ArticleId IdType="pmc">PMC8340726</ArticleId><ArticleId IdType="pubmed">34281357</ArticleId></ArticleIdList></Reference><Reference><Citation>Tehrani DM, Wang X, Rafique AM, Hayek SS, Herrmann J, Neilan TG, et al. . Impact of cancer and cardiovascular disease on in-hospital outcomes of COVID-19 patients: results from the american heart association COVID-19 cardiovascular disease registry. Cardiooncology. (2021) 7:28. 10.1186/s40959-021-00113-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40959-021-00113-y</ArticleId><ArticleId IdType="pmc">PMC8352751</ArticleId><ArticleId IdType="pubmed">34372948</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. (2020) 370:m3026. 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R&#x201e; et al. Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. ClinMed. (2021) 21:e63&#x2013;7. 10.7861/clinmed.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Health. Available online at: https://www.nih.gov/about-nih/whowe-are/nih-director/statements/nih-launches-new-initiative-studylong-covid (accessed April 5, 2020).</Citation></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hlberg M, Reistam U, Fedorowski A, Villacorta H, Horiuchi Y, Bax J, et al. . Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am J Med. (2021) 134:1451&#x2013;56. 10.1016/j.amjmed.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2021.07.004</ArticleId><ArticleId IdType="pmc">PMC8356730</ArticleId><ArticleId IdType="pubmed">34390682</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganatra S, Hammond SO, Nohria A. Novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer. JACC Cardio Oncol. (2020) 2:350&#x2013;5. 10.1016/j.jaccao.2020.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccao.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7151392</ArticleId><ArticleId IdType="pubmed">32292919</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, et al. . Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. (2020) 7:935&#x2013;41. 10.1158/2159-8290.CD-20-0516</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-20-0516</ArticleId><ArticleId IdType="pmc">PMC7334098</ArticleId><ArticleId IdType="pubmed">32357994</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai M, Liu D, Liu M, Zhou FX, Li GL, Chen Z, et al. . Patients with cancer appear more vulnerable to SARS-CoV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov. (2020) 10:783&#x2013;91. 10.1158/2159-8290.CD-20-0422</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/2159-8290.CD-20-0422</ArticleId><ArticleId IdType="pmc">PMC7309152</ArticleId><ArticleId IdType="pubmed">32345594</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Bhatt NS, St Martin A, Abid MB, Bloomquist J, Chemaly RF, et al. . Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. (2021) 8:e185&#x2013;93. 10.1016/S2352-3026(20)30429-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30429-4</ArticleId><ArticleId IdType="pmc">PMC7816949</ArticleId><ArticleId IdType="pubmed">33482113</ArticleId></ArticleIdList></Reference><Reference><Citation>Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, et al. . The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. (2020) 21:1023&#x2013;34. 10.1016/S1470-2045(20)30388-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(20)30388-0</ArticleId><ArticleId IdType="pmc">PMC7417808</ArticleId><ArticleId IdType="pubmed">32702310</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, et al. . Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. (2020) 371:m4087. 10.1136/bmj.m4087</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4087</ArticleId><ArticleId IdType="pmc">PMC7610021</ArticleId><ArticleId IdType="pubmed">33148535</ArticleId></ArticleIdList></Reference><Reference><Citation>Canale ML, Turazza F, Lestuzzi C, Parrini I, Camerini A, Russo G, et al. . Portrait of italian cardio-oncology: results of a nationwide associazione nazionale medici cardiologi ospedalieri (ANMCO) survey. Front Cardiovasc Med. (2021) 8:677544. 10.3389/fcvm.2021.677544</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.677544</ArticleId><ArticleId IdType="pmc">PMC8242580</ArticleId><ArticleId IdType="pubmed">34222373</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldassarre LA, Yang EH, Cheng RK, DeCara JM, Dent Susan, Liu Jennifer E, et al. . Cardiovascular care of the oncology patient during COVID-19: an expert consensus document from the ACC cardio-oncology and imaging councils. J Natl Cancer Inst. (2021) 113:513. 10.1093/jnci/djaa177</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djaa177</ArticleId><ArticleId IdType="pmc">PMC7717327</ArticleId><ArticleId IdType="pubmed">33179744</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, et al. . Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: an international cardio-oncology society (ICOS) statement. CA Cancer J Clin. (2020) 70:480&#x2013;504. 10.3322/caac.21635</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21635</ArticleId><ArticleId IdType="pmc">PMC7934086</ArticleId><ArticleId IdType="pubmed">32910493</ArticleId></ArticleIdList></Reference><Reference><Citation>Addison D, Campbell CM, Guha A, Ghosh AK, Dent SF, Jneid H. Cardio-Oncology in the Era of the COVID-19 pandemic and beyond. J Am Heart Assoc. (2020) 9:e017787. 10.1161/JAHA.120.017787</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.017787</ArticleId><ArticleId IdType="pmc">PMC7792393</ArticleId><ArticleId IdType="pubmed">32713239</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonergan PE, Washington Iii SL, Branagan L, Gleason N, Pruthi RS, Carroll PR, et al. . Rapid utilization of telehealth in a comprehensive cancer center as a response to COVID-19: cross-sectional analysis. J Med Internet Res. (2020) 22:e19322. 10.2196/19322</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/19322</ArticleId><ArticleId IdType="pmc">PMC7340164</ArticleId><ArticleId IdType="pubmed">32568721</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill S, Hao D, Hirte H, Campbell A, Colwell B. Impact of COVID-19 on Canadian medical oncologists and cancer care: Canadian association of medical oncologists survey report. Curr Oncol. (2020) 27:71&#x2013;74. 10.3747/co.27.6643</Citation><ArticleIdList><ArticleId IdType="doi">10.3747/co.27.6643</ArticleId><ArticleId IdType="pmc">PMC7253737</ArticleId><ArticleId IdType="pubmed">32489248</ArticleId></ArticleIdList></Reference><Reference><Citation>Berlin A, Lovas M, Truong T, Melwani S, Liu J, Liu ZA, et al. . Implementation and outcomes of virtual care across a tertiary cancer center during COVID-19. JAMA Oncol. (2021) 7:597&#x2013;602. 10.1001/jamaoncol.2020.6982</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2020.6982</ArticleId><ArticleId IdType="pmc">PMC7791400</ArticleId><ArticleId IdType="pubmed">33410867</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinesen B, Nonnecke B, Lindeman D, Toft E, Kidholm K, Jethwani K, et al. . Personalized telehealth in the future: a global research agenda. J Med Internet Res. (2016) 18:e53. 10.2196/jmir.5257</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.5257</ArticleId><ArticleId IdType="pmc">PMC4795318</ArticleId><ArticleId IdType="pubmed">26932229</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisk M, Livingstone A, Pit SW. Telehealth in the context of COVID-19: changing perspectives in Australia, the United Kingdom, and the United States. J Med Internet Res. (2020) 22:e19264. 10.2196/19264</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/19264</ArticleId><ArticleId IdType="pmc">PMC7286230</ArticleId><ArticleId IdType="pubmed">32463377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, et al. . Centre for the mathematical modelling of infectious diseases COVID-19 Working Group, Funk S, Eggo RM. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. (2020) 8:e488&#x2013;e496. 10.1016/S2214-109X(20)30074-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(20)30074-7</ArticleId><ArticleId IdType="pmc">PMC7097845</ArticleId><ArticleId IdType="pubmed">32119825</ArticleId></ArticleIdList></Reference><Reference><Citation>Congress.gov . H.R.6074 &#x2013; Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020. 116th Congress (2019-2020). Available online at: https://www.congress.gov/bill/116th-congress/house-bill/6074 (accessed July 19, 2021).</Citation></Reference><Reference><Citation>Fix OK, Serper M. Telemedicine and telehepatology during the COVID-19 pandemic. Clin Liver Dis. (2020) 15:187&#x2013;90. 10.1002/cld.971</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cld.971</ArticleId><ArticleId IdType="pmc">PMC7280602</ArticleId><ArticleId IdType="pubmed">32537134</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith AC, Thomas E, Snoswell CL, Haydon H, Mehrotra A, Clemensen J, et al. . Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare. (2020) 26:309&#x2013;13. 10.1177/1357633X20916567</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1357633X20916567</ArticleId><ArticleId IdType="pmc">PMC7140977</ArticleId><ArticleId IdType="pubmed">32196391</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CB, Bhardwaj AS. Disparities in the use of telehealth during the COVID-19 pandemic [abstract]. J Clin Oncol. (2020) 38(Suppl):87. 10.1200/JCO.2020.38.29_suppl.87</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2020.38.29_suppl.87</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwamm LH. Telehealth: seven strategies to successfully implement disruptive technology and transform health care. Health Aff . (2014) 33:200&#x2013;6. 10.1377/hlthaff.2013.1021</Citation><ArticleIdList><ArticleId IdType="doi">10.1377/hlthaff.2013.1021</ArticleId><ArticleId IdType="pubmed">24493761</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadler D, DeCara JM, Herrmann J, Arnold A, Ghosh AK, AbdelQadir H, et al. . Cardio-oncology international collaborative network. Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey. Cardio Oncol. (2020) 6:28. 10.1186/s40959-020-00085-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40959-020-00085-5</ArticleId><ArticleId IdType="pmc">PMC7691954</ArticleId><ArticleId IdType="pubmed">33292763</ArticleId></ArticleIdList></Reference><Reference><Citation>Duceppe E, Parlow J, MacDonald P, Lyons K, McMullen M, Srinathan S, et al. . Canadian cardiovascular society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery. Can J Cardiol. (2017) 33:17&#x2013;32. 10.1016/j.cjca.2016.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2016.09.008</ArticleId><ArticleId IdType="pubmed">27865641</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvillo-Arg&#xfc;elles O, Abdel-Qadir H, Ky B, Liu JE, Lopez-Mattei JC, Amir E, et al. . Modified routine cardiac imaging surveillance of adult cancer patients and survivors during the COVID-19 pandemic. JACC Cardio Oncol. (2020) 2:345&#x2013;9. 10.1016/j.jaccao.2020.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccao.2020.04.001</ArticleId><ArticleId IdType="pmc">PMC7162635</ArticleId><ArticleId IdType="pubmed">32309816</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Send&#xf3;n J, &#xc1;lvarez-Ortega C, Zamora Zamora Au&#xf1;on P. Bu&#xf1;o Soto A, Lyon AR, Farmakis D, et al. . Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry. Eur Heart J. (2020) 41:1720&#x2013;9. 10.1093/eurheartj/ehaa006</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa006</ArticleId><ArticleId IdType="pubmed">32016393</ArticleId></ArticleIdList></Reference><Reference><Citation>Moynihan R, Johansson M, Maybee A, Lang E, L&#xe9;gar&#xe9; F. Covid-19: an opportunity to reduce unnecessary healthcare. BMJ. (2020) 370:m2752. 10.1136/bmj.m2752</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2752</ArticleId><ArticleId IdType="pubmed">32665257</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi AD, Abbara S, Branch KR, Feuchtner GM, Ghoshhajra B, Nieman K, et al. . Society of cardiovascular computed tomography guidance for use of cardiac computed tomography amidst the COVID-19 pandemic endorsed by the American college of cardiology. J Cardiovasc Comput Tomogr. (2020) 14:101&#x2013;104. 10.1016/j.jcct.2020.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcct.2020.03.002</ArticleId><ArticleId IdType="pmc">PMC7102563</ArticleId><ArticleId IdType="pubmed">32317235</ArticleId></ArticleIdList></Reference><Reference><Citation>Society for Cardiovascular Magnetic Resonance. SCMR's COVID-19 Preparedness Toolkit. Chicago, IL: Society for Cardiovascular Magnetic Resonance; (2020).</Citation></Reference><Reference><Citation>European Society of Cardiology . Routine Cardiotoxicity Echo Screening for Chemotherapy Patients during COVID-19. Biot: European Society of Cardiology; (2020).</Citation></Reference><Reference><Citation>Cowie MR, O'Connor CM. The digital future is now. JACC Heart Filure. (2022) 10:67&#x2013;9. 10.1016/j.jchf.2021.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.11.003</ArticleId><ArticleId IdType="pmc">PMC8711689</ArticleId><ArticleId IdType="pubmed">34969500</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain A, Via G, Melniker L, Goffi A, Tavazzi G, Neri L, et al. . Multi-organ point-of-care ultrasound for COVID-19 (PoCUS4COVID): international expert consensus. Crit Care. (2020) 24:702. 10.1186/s13054-020-03369-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03369-5</ArticleId><ArticleId IdType="pmc">PMC7759024</ArticleId><ArticleId IdType="pubmed">33357240</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>